A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 400
- Registration Number
- NCT00000969
- Locations
- 🇺🇸
Comprehensive AIDS Alliance of Detroit, Detroit, Michigan, United States
🇺🇸Hill Health Corp, New Haven, Connecticut, United States
🇺🇸Wilmington Hosp / Med Ctr of Delaware, Wilmington, Delaware, United States
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 130
- Registration Number
- NCT00000779
- Locations
- 🇺🇸
UCLA CARE Center CRS, Los Angeles, California, United States
🇺🇸Santa Clara Valley Med. Ctr., San Jose, California, United States
🇺🇸NY Univ. HIV/AIDS CRS, New York, New York, United States
A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 15
- Registration Number
- NCT00000742
- Locations
- 🇺🇸
Univ. of Rochester ACTG CRS, Rochester, New York, United States
🇺🇸Washington U CRS, Saint Louis, Missouri, United States
🇺🇸USC CRS, Los Angeles, California, United States
A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 420
- Registration Number
- NCT00000871
- Locations
- 🇺🇸
Fenway Community Health Center HIVNET, Boston, Massachusetts, United States
🇺🇸Univ. of Pennsylvania HIVNET, Philadelphia, Pennsylvania, United States
🇺🇸Univ. of Illinois at Chicago HIVNET, Chicago, Illinois, United States
A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 60
- Registration Number
- NCT00000754
- Locations
- 🇺🇸
Alabama Therapeutics CRS, Birmingham, Alabama, United States
🇺🇸Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸Ucsd, Avrc Crs, La Jolla, California, United States
The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
- Conditions
- Herpes SimplexChickenpoxHIV Infections
Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 12
- Registration Number
- NCT00000876
- Locations
- 🇺🇸
Long Beach Memorial Med. Ctr., Miller Children's Hosp., Long Beach, California, United States
🇺🇸UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States
🇺🇸Univ. of Florida Jacksonville NICHD CRS, Jacksonville, Florida, United States
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
- Conditions
- Bacterial InfectionsPneumonia, Pneumocystis CariniiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 690
- Registration Number
- NCT00000811
- Locations
- 🇺🇸
Saint Christopher's Hosp for Children, Philadelphia, Pennsylvania, United States
🇵🇷San Juan City Hosp, San Juan, Puerto Rico
🇺🇸Texas Children's Hosp / Baylor Univ, Houston, Texas, United States
Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients
- Conditions
- HIV InfectionsPneumonia, Pneumocystis Carinii
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 240
- Registration Number
- NCT00000730
- Locations
- 🇺🇸
Julio Arroyo, West Columbia, South Carolina, United States
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
- Conditions
- Sarcoma, KaposiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 24
- Registration Number
- NCT00000660
- Locations
- 🇺🇸
Mem Sloan - Kettering Cancer Ctr, New York, New York, United States
🇺🇸Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
🇺🇸San Francisco Gen Hosp, San Francisco, California, United States